Shares of Cupid Ltd surged 5.56% to Rs 267.30 in Tuesday’s session, ahead of the company’s Q2 FY26 results expected later today. The stock traded in the range of Rs 253.23–Rs 273, touching a fresh 52-week high of Rs 273 on the NSE, with a market capitalization of Rs 6,831 crore.
Investor sentiment remained upbeat following the company’s earlier announcement that it expects its annual revenue from South Africa to cross Rs 115 crore, after securing the maximum allocation in the African nation’s five-year procurement programme for contraceptive products (2025–2030).
Cupid stated that the procurement rollout will begin in December 2025, and the company is working with approved South African distributors for a phased supply of male and female condoms. The total financial visibility under this programme is $12.98 million (approximately Rs 115 crore annually), marking a major milestone in Cupid’s global expansion strategy.
The company’s leadership position in the tender has strengthened its outlook in the health and wellness segment, with expectations of steady export growth and improved margins in upcoming quarters.
At 9:47 AM, over 2.8 million shares had changed hands on NSE, reflecting strong investor participation ahead of the earnings release.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
